Pulmonary · Topic 2 of 28
Acute Respiratory Distress Syndrome (ARDS)
Tap any line to see why it matters
Acute Respiratory Distress Syndrome (ARDS)
Bilateral noncardiogenic edema with P/F ≤ 300 on PEEP ≥ 5. Ventilate at 6 mL/kg ideal body weight, keep plateau ≤ 30, prone the severe.
Why it happens
A leaky alveolar–capillary membrane floods the lung at normal pressures
Inflammatory injury moves from an exudative phase to a fibroproliferative phase.
What causes it
Sepsis and pneumonia cause most cases
Diagnosis: Berlin definition
All four, then grade by P/F on PEEP ≥ 5
Berlin remains the board standard. The 2023 global definition keeps these criteria and cut-offs for intubated patients, and adds patients on high-flow oxygen ≥ 30 L/min, SpO₂/FiO₂ ≤ 315 (when SpO₂ ≤ 97%) in place of an ABG, and lung ultrasound for bilateral opacities.
Red flags
High-frequency oscillatory ventilation is strongly recommended against in moderate–severe ARDS. Inhaled nitric oxide and surfactant do not reduce morbidity or mortality.
Treatment
Protect the lung — low tidal volume cuts mortality
6 mL/kg ideal body weight, from height and sex
Plateau over 30: cut 0.5–1 mL/kg, floor 4 mL/kgEnd-inspiratory hold every 4 h and after each change
Target 30 cmH₂O or lessLowest FiO₂ that reaches SpO₂ 88–95%, ideally ≤ 0.6
Normal saturations are not the goalRaise rate up to 35/min; accept pH down to about 7.15
Don't enlarge the breaths to clear CO₂Prone over 12 hours a day — improves survival
Also used in moderate–severe ARDSConsider within 48 h of onset with P/F ≤ 100
Always with adequate sedationATS 2024 suggests corticosteroids in adult ARDS
Conditional, moderate certaintyConsider if P/F under 80, or pH under 7.25 with PaCO₂ ≥ 60, under 7 days in
High-volume center, after proning and paralysis failFluids and outcomes
ATS words the plateau limit as under 30 cmH₂O; ARDSNet targets ≤ 30. PROSEVA: prone sessions of at least 16 h with P/F under 150 on FiO₂ ≥ 0.6. Paralysis is a conditional ATS 2024 suggestion; Merck does not recommend it routinely after a larger trial showed no benefit. Merck still calls steroid data in non-COVID ARDS inconclusive.
ARDS or cardiogenic pulmonary edema?
| ARDS | Cardiogenic edema | |
|---|---|---|
| Mechanism | Leaky alveolar–capillary membrane (low pressure) | High capillary hydrostatic pressure |
| Examination | No S3; signs of the trigger (sepsis, pneumonia) | S3, JVD, peripheral edema |
| Chest x-ray | Bilateral, more peripheral opacities | Central opacities, cardiomegaly, wide vascular pedicle |
| Oxygen response | Shunt: hypoxemia resists high FiO₂ | Improves fast with diuretics and CPAP/BiPAP |
| Definition clause | Not fully explained by heart failure or fluid overload | Explained by LV failure or volume |
LV dysfunction on echo is nonspecific in sepsis.
Protect the lung, not the blood gas: small breaths, plateau ≤ 30, accept some CO₂ and SpO₂ 88–95%.
Sources · Acute Hypoxemic Respiratory Failure, Including ARDS (Merck Manual Professional) · ARDS: the Berlin definition (JAMA 2012) · ATS/ESICM/SCCM guideline: mechanical ventilation in adult ARDS (2017) · ATS guideline update: management of adult ARDS (2024) · A new global definition of ARDS (AJRCCM 2024) · Overview of Mechanical Ventilation (Merck Manual Professional) · NHLBI ARDS Network mechanical ventilation protocol summary · Prone positioning in severe ARDS: PROSEVA (NEJM 2013) · Follow your institution's protocols.